Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

  • Etude concernée: IFCT-0101
  • Auteurs / Authors: Girard N, Mornex F, Douillard JY, Bossard N, Quoix E, Beckendorf V, Grunenwald, Amour E, Milleron B.
  • Journal / Conference: Lung Cancer
  • Année / Year: 2010
  • PMID: 19879013
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/19879013